Stella Diagnostics, Inc. (SLDX)

Market Cap	4.82M -92.4%
Revenue (ttm)	n/a
Net Income	-257.97K
EPS	-7.53
Shares Out	301.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	310
Average Volume	9,708
Open	0.0160
Previous Close	n/a
Day's Range	0.0160 - 0.0160
52-Week Range	0.0111 - 0.0520
Beta	0.25
RSI	43.31
Earnings Date	n/a

About Stella Diagnostics

Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in A...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: David Seaburg
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: SLDX